Table 2.
Cumulated number of cancers in different high and low risk subgroups at 6-, 12- and 24-months follow up visits after the S2 screening date
Number of individuals | Cumulative number of cancers diagnosed at follow up visit | |||||
---|---|---|---|---|---|---|
6 months | 12 months | 24 months | 36 months | |||
NLST training sample | ||||||
Total screened | 25097 | 274 | 358 | 464 | 574 | |
High-risk subgroup | Lung-RADS=4B | 561 | 170 | 194 | 212 | 221 |
Lung-RADS= 4A/4B/4X | 1333 | 227 | 274 | 308 | 327 | |
ML>0.3 | 392 | 260 | 313 | 344 | 353 | |
Low-risk subgroup | Lung-RADS=1 or 2 | 23458 | 43 | 75 | 145 | 234 |
ML ≤ 0.1 | 24234 | 6 | 15 | 51 | 95 | |
PanCan validation sample | ||||||
Total screened | 2294 | 43 | 54 | 72 | 92 | |
High-risk subgroup | Lung-RADS=4B | 97 | 35 | 38 | 44 | 49 |
Lung-RADS=4A/4B/4X | 235 | 41 | 48 | 58 | 65 | |
VDT < 400 days | 192 | 29 | 31 | 36 | 44 | |
ML>0.3 | 221 | 41 | 51 | 61 | 65 | |
Low-risk subgroup | Lung-RADS=1 or 2 | 1698 | 1 | 3 | 9 | 20 |
ML ≤ 0.1 | 1266 | 0 | 0 | 2 | 10 | |
VDT >600 days | 2075 | 13 | 19 | 31 | 43 |